Veracyte IO (also known as HalioDx) is an immuno-oncology diagnostic company providing oncologists with immune-based diagnostic products and services. Its technology integrates immunohistochemistry combined with advanced imaging analysis enabling extraction of spatially-organized tissue molecular information. The company develops a platform for cancers, as an immune response to the tumor is a key hallmark of disease progression.